| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.06 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |